Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cleveland Clinic, Cleveland, OH, USA.
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA; Center for Populations Health Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Gynecol Oncol. 2022 Sep;166(3):379-388. doi: 10.1016/j.ygyno.2022.07.003. Epub 2022 Jul 19.
To evaluate if the 5-factor modified frailty index (mFI) is associated with postoperative complications, readmissions or non-home discharge in gynecologic cancer patients undergoing surgery.
Patients with a diagnosis of gynecologic cancer (cervical, uterine, or ovarian cancer) who underwent surgery between 2014 and 2018 were identified through the National Surgical Quality Improvement Program (NSQIP) database. The 5-factor mFI was applied and patients classified into 6 categories (mFI groups 0,1,2, 3, 4 and 5). The incidence of 30-day complications, readmissions and non-home discharge was evaluated. Multivariable logistic regression models were used to determine the association between mFI category and readmissions/ complications. Adjusted probabilities of events were calculated based on patient characteristics.
At total of 31,181 gynecologic cancer cases were included in the analysis: N = 2968 (9.4%) cervical, N = 20,862 (66.4%) uterine, and N = 7351 (23.4%) ovarian cancers. Of all patients, 46.1% were in category 0, 36.5% category 1, and 1% category 3-5. Factors associated with increased mFI included older age, African American race, laparoscopic surgery and obesity. A significant dose-response relationship between higher mFI and readmission and 30-day complications was noted on adjusted multivariable analysis (adjusted OR 2.37 (1.65-3.45) and 2.10 (1.59-2.75) for readmissions and complications, respectively, in mFI category 3-5). These associations were consistent within each cancer type.
The 5-factor mFI universally predicts postoperative readmissions, 30-day complications and non-home discharge in patients with gynecologic cancer. Incorporation of mFI into routine preoperative assessment can identify patients for non-surgical treatments, prehabiliatation and short term home assessments.
评估五因素改良衰弱指数(mFI)是否与妇科癌症患者手术术后并发症、再入院或非出院回家相关。
通过国家外科质量改进计划(NSQIP)数据库,确定 2014 年至 2018 年间诊断为妇科癌症(宫颈癌、子宫癌或卵巢癌)并接受手术的患者。应用五因素 mFI 并将患者分为 6 组(mFI 组 0、1、2、3、4 和 5)。评估 30 天内并发症、再入院和非出院回家的发生率。使用多变量逻辑回归模型确定 mFI 类别与再入院/并发症之间的关系。根据患者特征计算事件的调整后概率。
共纳入 31181 例妇科癌症病例进行分析:n = 2968(9.4%)宫颈癌,n = 20862(66.4%)子宫癌,n = 7351(23.4%)卵巢癌。所有患者中,46.1%为 0 组,36.5%为 1 组,1%为 3-5 组。与 mFI 增加相关的因素包括年龄较大、非裔美国人种族、腹腔镜手术和肥胖。调整后的多变量分析显示,mFI 较高与再入院和 30 天并发症之间存在显著的剂量反应关系(mFI 3-5 组的调整后比值比[OR]分别为 2.37(1.65-3.45)和 2.10(1.59-2.75))。在每种癌症类型中,这些关联都是一致的。
五因素 mFI 普遍预测妇科癌症患者术后再入院、30 天并发症和非出院回家。在常规术前评估中纳入 mFI 可以识别需要非手术治疗、康复前和短期家庭评估的患者。